NCT06796907 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06796907
Title	A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Acronym	BEHOLD-2
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	GlaxoSmithKline
Indications	Advanced Solid Tumor ovarian cancer peritoneum cancer fallopian tube cancer ovary epithelial cancer endometrial cancer
Therapies	GSK5733584 Bevacizumab + GSK5733584 Dostarlimab-gxly + GSK5733584
Age Groups:	senior \| adult
Covered Countries	TUR \| SWE \| POL \| NOR \| NLD \| GRC \| GBR \| FRA \| FIN \| ESP \| DNK \| DEU \| CAN \| BRA \| BEL \| AUS \| ARG

NCT06796907
Clinical Trial Detail